fluorobenzenes has been researched along with Ventricular Dysfunction, Left in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ara, N; Iuchi, A; Miyoshi, H; Mizuguchi, Y; Nagase, N; Oishi, Y; Oki, T | 1 |
| Badar, AA; Cleland, JG; Gardner, RS; Hawkins, NM; Jhund, PS; Kjekshus, J; McMurray, JJ; Perez-Moreno, AC; Petrie, MC; van Veldhuisen, DJ; Watkins, S; Wedel, H; Wikstrand, J; Wong, CM | 1 |
| Capurso, A; Capurso, C; Colacicco, AM; D'Introno, A; Frisardi, V; Gadaleta, A; Panza, F; Santamato, A; Solfrizzi, V | 1 |
| Chang, SA; Kim, DH; Kim, HK; Kim, YJ; Oh, BH; Park, YB; Sohn, DW | 1 |
| Barros, IM; Kristensen, SD; Moura, LM; Pinto, FJ; Ramos, SF; Rocha-Gonçalves, F | 1 |
| Bianchi, C; Canale, ML; Del Prato, S; Delle Donne, MG; Di Bello, V; Mariani, M; Miccoli, R; Nardi, C; Palagi, C; Penno, G; Talini, E | 1 |
| Goldstein, S; Imai, M; Jiang, A; Rastogi, S; Sabbah, HN; Sharov, VG; Wang, M; Zacà, V | 1 |
| Mascitelli, L; Pezzetta, F | 1 |
| Rahimtoola, SH | 1 |
| Chan, KL; Dumesnil, JG; Giannoccaro, PJ; Jassal, DS; Joyner, CD; Jue, J; Pandey, AS; Tam, JW; Teo, KK | 1 |
1 review(s) available for fluorobenzenes and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
The year in valvular heart disease.
Topics: Animals; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Arabidopsis Proteins; Bioprosthesis; Body Surface Area; Catheterization; Cholesterol, LDL; Coronary Disease; Disease Progression; Echocardiography, Three-Dimensional; Endocarditis, Bacterial; Fluorobenzenes; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mitral Valve Insufficiency; Mitral Valve Stenosis; Odds Ratio; Practice Guidelines as Topic; Prosthesis Design; Prosthesis Fitting; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Tomography, X-Ray Computed; Treatment Outcome; Tricuspid Valve Insufficiency; Ventricular Dysfunction, Left | 2008 |
6 trial(s) available for fluorobenzenes and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Influence of comorbid cardiovascular risk factors on left atrial-left ventricular interaction in asymptomatic patients: clinical application of two-dimensional speckle-tracking echocardiography.
Topics: Aged; Atherosclerosis; Atrial Function, Left; Carotid Intima-Media Thickness; Dose-Response Relationship, Drug; Double-Blind Method; Echocardiography; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Prospective Studies; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides; Ventricular Dysfunction, Left; Ventricular Function, Left | 2014 |
Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Topics: Aged; Angina Pectoris; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Pyrimidines; Retrospective Studies; Rosuvastatin Calcium; Stroke Volume; Sulfonamides; Treatment Outcome; Ventricular Dysfunction, Left | 2014 |
Persistent regional diastolic dysfunction after myocardial ischemia and the effect of statin treatment: assessment with two-dimensional radial strain rate.
Topics: Angina Pectoris, Variant; Atorvastatin; Diastole; Exercise Test; Female; Fluorobenzenes; Heart; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Pyrimidines; Pyrroles; Reference Standards; Rosuvastatin Calcium; Sulfonamides; Ultrasonography; Ventricular Dysfunction, Left | 2010 |
Rosuvastatin slows the development of diastolic dysfunction in calcific aortic stenosis.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Calcinosis; Diastole; Disease Progression; Echocardiography; Female; Fluorobenzenes; Follow-Up Studies; Heart Failure, Diastolic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Ventricular Dysfunction, Left | 2012 |
Early impairment of left ventricular function in hypercholesterolemia and its reversibility after short term treatment with rosuvastatin A preliminary echocardiographic study.
Topics: Adult; Blood Flow Velocity; Densitometry; Diastole; Echocardiography, Doppler, Color; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Middle Aged; Pilot Projects; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Systole; Ventricular Dysfunction, Left | 2008 |
Clinical usefulness of tissue Doppler imaging in patients with mild to moderate aortic stenosis: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aortic Valve Stenosis; Echocardiography, Doppler; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prognosis; Pyrimidines; Reproducibility of Results; Rosuvastatin Calcium; Sensitivity and Specificity; Sulfonamides; Treatment Outcome; Ventricular Dysfunction, Left; Young Adult | 2008 |
3 other study(ies) available for fluorobenzenes and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure.
Topics: Aged; Cholesterol; Coronary Disease; Dementia; Fluorobenzenes; Geriatrics; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides; Ventricular Dysfunction, Left | 2008 |
Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure.
Topics: Animals; Coronary Angiography; Dogs; Fluorobenzenes; Heart Failure; Hematopoietic Stem Cells; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase 2; Myocardium; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left; Ventricular Remodeling | 2007 |
Does hypercholesterolemia impair left ventricular function?
Topics: Case-Control Studies; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Pyrimidines; Rosuvastatin Calcium; Selection Bias; Sulfonamides; Ventricular Dysfunction, Left | 2008 |